Gan LM, Hage C, Lund LH. Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF. J Card Fail. 2021 Jul;27(7):756-765. \[[PubMed: 33647474](https://pubmed.ncbi.nlm.nih.gov/33647474)\] 61. Leggat J, Bidault G, Vidal-Puig A. Lipotoxicity: a driver of heart failure with preserved ejection fraction? Clin Sci (Lond). 2021 Oct 15;135(19):2265-2283. \[[PMC free article: PMC8543140](/pmc/articles/PMC8543140/)\] \[[PubMed: 34643676](https://pubmed.ncbi.nlm.nih.gov/34643676)\] 62. Gerhardt LMS, Kordsmeyer M, Sehner S, Güder G, Störk S, Edelmann F, Wachter R, Pankuweit S, Prettin C, Ertl G, Wanner C, Angermann CE. Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages. Clin Res Cardiol. 2023 Jul;112(7):868-879. \[[PMC free article: PMC10293329](/pmc/articles/PMC10293329/)\] \[[PubMed: 35648270](https://pubmed.ncbi.nlm.nih.gov/35648270)\] 63. Cuthbert JJ, Pellicori P, Rigby A, Pan D, Kazmi S, Shah P, Clark AL. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. Eur J Heart Fail. 2018 Oct;20(10):1426-1435. \[[PubMed: 29943886](https://pubmed.ncbi.nlm.nih.gov/29943886)\] 64. Li Y, Li J. Analysis of Risk Factors for Heart Failure with Preserved Ejection Fraction and Observations on Blood Lipid Metabolism. Altern Ther Health Med. 2023 Nov;29(8):396-400. \[[PubMed: 37632969](https://pubmed.ncbi.nlm.nih.gov/37632969)\] 65. Zhou Q, Yang J, Tang H, Guo Z, Dong W, Wang Y, Meng X, Zhang K, Wang W, Shao C, Hua X, Tang YD. High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction. Cardiovasc Diabetol. 2023 Sep 29;22(1):263. \[[PMC free article: PMC10541699](/pmc/articles/PMC10541699/)\] \[[PubMed: 37775762](https://pubmed.ncbi.nlm.nih.gov/37775762)\] 66. Salah HM, Pandey A, Soloveva A, Abdelmalek MF, Diehl AM, Moylan CA, Wegermann K, Rao VN, Hernandez AF, Tedford RJ, Parikh KS, Mentz RJ, McGarrah RW, Fudim M. Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction. JACC Basic Transl Sci. 2021 Nov;6(11):918-932. \[[PMC free article: PMC8617573](/pmc/articles/PMC8617573/)\] \[[PubMed: 34869957](https://pubmed.ncbi.nlm.nih.gov/34869957)\] 67. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD., CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. Eur Heart J. 2015 Mar 14;36(11):657-68. \[[PMC free article: PMC4359359](/pmc/articles/PMC4359359/)\] \[[PubMed: 25176939](https://pubmed.ncbi.nlm.nih.gov/25176939)\] 68. De Luca M, Crisci G, Giardino F, Valente V, Amaranto I, Iacono O, D'Assante R, Giallauria F, Marra AM. Anabolic hormones and heart failure with preserved ejection fraction: looking for Ariadne's thread. Monaldi Arch Chest Dis. 2021 Aug 03;92(1) \[[PubMed: 34351104](https://pubmed.ncbi.nlm.nih.gov/34351104)\] 69. Waddell-Smith KE, Donoghue T,